Thalanga Operations quarterly EBITDA (unaudited) was $1.7 million, an increase of $0.4 million over the prior quarter. Revenue was $1.9 million higher than the previous quarter due to increased sales of zinc and lead concentrate. Sales realisation expenses were $1.9 million higher than the previous quarter due to increased concentrate sales and increased zinc concentrate treatment charges (increased by approx. US$120 per tonne of concentrate during the quarter)
RVR Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held